News
B. Riley Securities Maintains Buy on Perspective Therapeutics, Raises Price Target to $1.7
9 Apr 24
News, Price Target, Analyst Ratings
Stocks Pause As Traders Reassess Interest Rate Path, Gold Makes New Highs, Bitcoin Rebounds: What's Driving Markets Thursday?
28 Mar 24
Analyst Color, Cryptocurrency, Equities, Large Cap, Broad U.S. Equity ETFs, Commodities, Top Stories, Economics, Federal Reserve, Intraday Update, Markets, Analyst Ratings, ETFs
Perspective Therapeutics FY2023 EPS $(0.14) Down From $(0.06) YoY, Sales $1.43M
28 Mar 24
Earnings, News
Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility; Financial Terms Not Disclosed
5 Mar 24
M&A
Perspective Therapeutics Announces $87.4M Private Placement Of 92,009,981 Shares Of Its Common Stock At A Price Of $0.95 Per Share
4 Mar 24
News, Offerings
12 Health Care Stocks Moving In Thursday's After-Market Session
15 Feb 24
Movers
12 Health Care Stocks Moving In Friday's After-Market Session
9 Feb 24
Movers
Press releases
Perspective Therapeutics to Participate at Upcoming May Investor Conferences
3 May 24
Press Releases
Perspective Therapeutics to Provide Recent Business Highlights and Report First Quarter 2024 Financial Results
2 May 24
Press Releases
Lantheus Reports First Quarter 2024 Financial Results
2 May 24
Earnings, Press Releases
Perspective Therapeutics Selected by FDA to Participate in the CDRP Program to Expedite Chemistry, Manufacturing, and Controls Development Readiness for VMT-α-NET in NETs
30 Apr 24
Press Releases
Perspective Therapeutics to Participate at Upcoming April Investor Conferences
8 Apr 24
Press Releases
Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results
28 Mar 24
Earnings, Press Releases
Perspective Therapeutics Announces $87.4 Million Private Placement
4 Mar 24
Press Releases